Haisco Pharmaceutical Hits Day High with 4% Surge Amid Market Decline

Haisco Pharmaceutical Group Co., Ltd. has shown significant activity today, gaining 4.0% on June 10, 2026. The stock reached an intraday high of CNY 49.84, reflecting a strong performance compared to the broader market, as the China Shanghai Composite index declined by 0.42% on the same day. Over the past week, Haisco has increased by 0.92%, while its performance over the past month shows a decline of 10.24%. However, the company has demonstrated resilience with a notable 11.63% increase over the past year, despite the Shanghai Composite's higher annual growth of 17.97%. Haisco's financial metrics indicate a robust operational framework, with a remarkable net profit growth of 1089.85% reported in March 2026. The company boasts a strong operating cash flow of CNY 1,126.55 million and a return on capital employed (ROCE) of 17.13%. Additionally, the reduction in raw material costs by 19.75% year-over-year has positively impacted its financial health. With a market capitalization of CNY 24,889 million, Haisco continues to maintain a competitive position in the pharmaceuticals and biotechnology sector.